New radiation therapy technology takes weeks off of lung cancer treatments - Elekta's Versa HD™
9/23/2013
On September 4, Kettering Medical Center (Kettering, Ohio) became the first clinic in North America to use Elekta's Versa HD™ system to treat a patient, a 71-year-old woman with medically inoperable lung cancer. The rapid speed of radiosurgery with Versa HD enabled Kettering physicians to reduce the number of treatment sessions for this patient from seven weeks to three days...
Biomarker identified for smoker's lung cancer
9/23/2013
Mayo Clinic researchers have shown that a specific protein pair may be a successful prognostic biomarker for identifying smoking-related lung cancers. The protein - ASCL1 - is associated with increased expression of the RET oncogene, a particular cancer-causing gene called RET. The findings appear in the online issue of the journal Oncogene...
Diagnosing diseases, such as cancer, heart disease and Alzheimer's, at their earliest stages and monitoring the earliest responses to therapy, requires careful detection of molecular biomarkers...
Hope for better cancer treatment offered by new protein knowledge
9/23/2013
When the pharmaceutical industry develops new medicines- for example for cancer treatment - it is important to have detailed knowledge of the body's molecular response to the medicine. "With a better knowledge of the many complex processes which are activated in connection with illness and medication, the better the possibility of developing new drugs...
Diagnosing early liver cancer with new test
9/23/2013
Researchers have found a way to make early liver cancer show its true colors. They have developed a test that will help pathologists clearly distinguish early liver cancer cells from nearly identical normal liver cells by giving them a distinctive red-brown hue...
Better treatments likely with new models of drug-resistant breast cancer
9/23/2013
Breast cancer that spreads to other organs is extremely difficult to treat. Doctors can buy patients time, but a cure remains elusive. Now, researchers at Washington University School of Medicine in St. Louis have shown that human breast tumors transplanted into mice are excellent models of metastatic cancer and could be valuable tools in the search for better treatments...
Missing immune response may prove a vital link for new leukaemia treatments
9/23/2013
Patients suffering from leukaemia could have their immune system engineered to fight the disease, after scientists at the University of Birmingham discovered that they lacked an immune response to a certain class of proteins which could be restored through stem cell transplants...
New radiation therapy technology takes weeks off of lung cancer treatments - Elekta's Versa HD™
9/23/2013
On September 4, Kettering Medical Center (Kettering, Ohio) became the first clinic in North America to use Elekta's Versa HD™ system to treat a patient, a 71-year-old woman with medically inoperable lung cancer. The rapid speed of radiosurgery with Versa HD enabled Kettering physicians to reduce the number of treatment sessions for this patient from seven weeks to three days...
It is difficult to underestimate the importance of telomerase, an enzyme that is the hallmark of both aging and the uncontrolled cell division associated with cancer. In an effort to understand and control telomerase activity, researchers at The Wistar Institute have discovered a protein "motif," named TFLY, which is crucial to the function of telomerase...
Mass-spectrometry-based method adapted to profile ribsomes and associated factors
9/23/2013
In molecular biology, the ribosome represents the machinery necessary to assemble proteins, the building blocks of life. In this process, information encoded in the genome's DNA is first transcribed to messenger RNA in the nucleus, then transported to the ribosome where protein-assembly instructions are put in motion to translate the code into actual proteins...